A Perspective on the Use of Poisson Versus Logistic Regression in Exposure–Response Analysis: Insights and Considerations
CPT: Pharmacometrics & Systems Pharmacology · 2025
DOI: 10.1002/psp4.70100 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2025. Verfasst von Yiming Cheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, Bristol Myers Squibb, Princeton, New Jersey, USA. Hauptthemen laut MEDLINE: Drug Development. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This perspective evaluates the use of Poisson versus logistic regression in modeling binary exposure‐response (ER) data. Through simulation studies across varying sample sizes, event rates, and ER slopes, we highlight the strengths and limitations of each method. Our findings show that Poisson regression is suitable under low event rates, while logistic regression provides consistent performance across broader scenarios. These insights help guide model selection and improve the robustness of ER analyses in drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinical Pharmacology, Bristol Myers Squibb, Princeton, New Jersey, USA.
Zitieren
APA
Cheng, Y., Chen, P., & Li, Y. (2025). A Perspective on the Use of Poisson Versus Logistic Regression in Exposure–Response Analysis: Insights and Considerations. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70100
Vancouver
Cheng Y, Chen P, Li Y. A Perspective on the Use of Poisson Versus Logistic Regression in Exposure–Response Analysis: Insights and Considerations. CPT: Pharmacometrics & Systems Pharmacology. 2025. doi:10.1002/psp4.70100
BibTeX
@article{Cheng2025,
author = {Cheng, Yiming and Chen, Ping and Li, Yan},
title = {A Perspective on the Use of Poisson Versus Logistic Regression in Exposure–Response Analysis: Insights and Considerations},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2025},
doi = {10.1002/psp4.70100}
}
EUVIMED